• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Johns Hopkins Arthritis Center

Show Search
Hide Search
  • Disease Information
    • Rheumatoid Arthritis
    • Psoriatic Arthritis
    • Ankylosing Spondylitis
    • Osteoarthritis
    • Gout
    • Osteoporosis
  • Patient Corner
    • Drug Information Sheets
    • Managing Your Arthritis
    • RheumTV – Patient Education Video Library
  • Our Research
    • Patient-Centered Outcomes Research
    • Current Research Studies
    • The Camille Julia Morgan Arthritis Research and Education Fund
  • About Us
    • Appointment Information
    • Contact Us
    • Our Faculty
    • Our Staff
    • Rheumatology Specialty Centers
    • News & Updates
  • Donate
Home / Patient Corner / Drug Information Sheets / Tofacitinib (Xeljanz®/XeljanzXR®)

Tofacitinib (Xeljanz®/XeljanzXR®)

What is Tofacitinib (Xeljanz®/xeljanzXR®)?

Tofacitinib is a prescription medicine called a Janus kinase (JAK) inhibitor. Tofacitinib is a treatment for adults with moderate to severe rheumatoid arthritis (RA), if methotrexate did not work for them. Tofacitinib is commonly known as Xeljanz® or XeljanzXR®.

How do I take it?

Tofacitinib is a pill. You may be prescribed one of 2 forms. Xeljanz® is a 5 mg tablet taken twice a day or XeljanzXR®, an 11mg extended release tablet that you take once a day. Your rheumatologist will decide which is best for you.

What about side effects?

  • Some people have serious infections while taking Tofacitinib. You should call your doctor if you think you have an infection.
  • Let your rheumatologist know if you live or have lived in places where fungal infections are more common. For example, histoplasmosis is more common in the Ohio River Valley.
  • You should have a TB (tuberculosis) test and a test for hepatitis B before beginning Tofacitinib.
  • There have been some cases of tears in the stomach or intestines, call your doctor if you have fever and stomach pain or there is a change in your bowel habits.
  • Other side effects may include changes in your liver and other blood tests. It is important to have any blood tests that your doctor orders. Your doctor will monitor this blood work to look for problems.
  • You should let your doctor know if you are planning any surgery. Tofacitinib affects your immune system and may affect healing.

What about other medications?

When you are taking Tofacitinib, it is very important that your doctors know if you are taking any other medicine. This includes prescription and non-prescription medicines as well as birth control pills, vitamins, and herbal supplements.

What else should I know?

You must continue your regular visits to the rheumatologist. Your doctor will monitor you for any improvements in your disease and for any signs of infections. Most patients notice an improvement in symptoms by one month of starting treatment. Your rheumatologist may want to make sure you have had any needed vaccines before starting this medication.  Live vaccines, such as the shingles vaccine, should not be given while on Tofacitinib.  You should get the flu shot every year; this is not a live vaccine.

 A Federal Drug Administration patient information guide is available online at:

  • http://labeling.pfizer.com/ShowLabeling.aspx?id=959
Receive the Latest News from Johns Hopkins Rheumatology

Receive the Latest News from Johns Hopkins Rheumatology

Join our mailing list to receive the latest news and updates from Johns Hopkins Rheumatology.

Interested In

You have Successfully Subscribed!

Use of this Site

All information contained within the Johns Hopkins Arthritis Center website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site. Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website.

Primary Sidebar

Drug Information

  • Drug Information Sheets
  • How to Give a Subcutaneous Injection

List of Treatments

  • Abatacept (Orencia®)
  • Adalimumab (Humira®)
  • Alendronate (Fosamax®)
  • Anakinra (Kineret®)
  • Apremilast (Otezla®)
  • Azathioprine (Imuran®)
  • Certolizumab (Cimzia®)
  • Corticosteroids (i.e. Prednisone)
  • Etanercept (Enbrel®)
  • Febuxostat (Uloric®)
  • Golimumab (Simponi®)
  • Golimumab for infusion (Simponi Aria®)
  • Hyaluronate (Synvisc® & Hyalgan®)
  • Hydroxychloroquine (Plaquenil®)
  • Ibandronate Sodium (Boniva®)
  • Infliximab (Remicade®)
  • Leflunomide (Arava®)
  • Lesinurad/Allopurinol (Duzallo®)
  • Lesinurad (Zurampic®)
  • Methotrexate (Oral)
  • Methotrexate (Injection)
  • Non-Steroidal Anti-inflammatory Drugs
  • Pegloticase (KRYSTEXXA®)
  • Probenecid
  • Risedronate (Actonel®)
  • Rituximab (Rituxan®)
  • Sarilumab (Kevzara®)
  • Secukinumab (Cosentyx®)
  • Sulfasalazine (Azulfidine®)
  • Teriparatide (Forteo®)
  • Tocilizumab (Actemra®)
  • Tofacitinib (Xeljanz®/XeljanzXR®)
  • Ustekinumab (Stelara®) Drug Information Sheet
  • Zolendronic Acid (Reclast®)
RheumTV Logo

Rheum.TV is an informational platform created to educate patients living with a rheumatic disease. With over 100 disease education videos produced by the team at Johns Hopkins Rheumatology.

Visit Rheum.TV

Footer

Johns Hopkins Rheumatology

  • Johns Hopkins Rheumatology
  • Johns Hopkins Lupus Center
  • Johns Hopkins Lyme Disease Research Center
  • Johns Hopkins Myositis Center
  • Johns Hopkins Scleroderma Center
  • Johns Hopkins Sjögren’s Syndrome Center
  • Johns Hopkins Vasculitis Center

Connect With Us

  • Facebook
  • Twitter
  • YouTube

Johns Hopkins Medicine

© 2025 Johns Hopkins Arthritis Center
Patient Privacy